Print this page Email this page | Users Online: 53
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2017  |  Volume : 8  |  Issue : 2  |  Page : 58-63

In vivo evaluation of honey as a new medicament for vital pulp therapy in primary teeth

1 Department of Pedodontics and Preventive Dentistry, Dr. Shyamala Reddy Dental College, Bengaluru, Karnataka, India
2 Department of Pedodontics and Preventive Dentistry, Sibar Institute of Dental Sciences, Guntur, Andhra Pradesh, India
3 Department of Pedodontics and Preventive Dentistry, Pananeeya Dental College, Hyderabad, Andhra Pradesh, India

Correspondence Address:
A Jogendra Sai Sankar
Department of Pedodontics and Preventive Dentistry, Sibar Institute of Dental Sciences, Guntur, Andhra Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/srmjrds.srmjrds_82_16

Rights and Permissions

Objectives: In spite of clinical success, the pulpotomy technique has been questioned for safety and effectiveness of currently available medicaments. In search of newer materials, there is a rapid research toward natural health remedies. Thus, an in vivo study was conducted to evaluate and compare the clinical and radiographic success of honey and formocresol (FC) as pulpotomy agents. Materials and Methods: A total of 100 mandibular primary molars were selected from 50 healthy children aged between 3 and 8 years following the inclusion and exclusion criteria for pulpotomy procedure. The teeth were divided into two equal groups; in Group A, honey was used as pulpal medicament and in Group B, FC as control. Further, all the pulpotomised teeth were restored with stainless steel crowns and postoperative evaluation was done at 1, 3, 6, 9, and 12 months interval. Results: Clinically, both the groups showed 100% success during the follow-up periods. Even though 100% radiographic success was recorded for Group A and B after 1 month interval, the values dipped to 95.6% and 95.4% at 3 months, 91.3% and 90.9% after 6 months, 91.3% and 86.3% after 9 months, and 86.9% and 77.2% after 12 months, respectively. Conclusion: Although honey showed promising results both clinically and radiographically, long-term follow-up is recommended to investigate the efficacy of honey as viable alternative to FC.

Print this article     Email this article
Next article
Previous article
Table of Contents

Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Citation Manager
Access Statistics
Reader Comments
Email Alert*
Add to My List*
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded498    
    Comments [Add]    

Recommend this journal